GLP-1 drugs

knownwell headquarters and clinic in Boston. [Photo: knownwell]

Co-Founded by a Dallas Native, Boston Metabolic Health Startup knownwell To Open Clinic in Plano

by | Jun 24, 2024
knownwell was co-founded by CEO Brooke Boyarsky Pratt in 2022 to "lead a shift in the narrative from health systems, payors, and employers having a GLP-1 strategy, to them having a comprehensive obesity treatment strategy." With a recent $20 million Series A, new C-suite hires, and an AI-powered acquisition just last week, the startup's expansion has just begun.
MORE►
The Last Word: Anton Pil of JPMorgan Chase on the Impact of Drugs Like Ozempic on People’s Spending Patterns
by | Jan 19, 2024
“GLP-1 drugs, medications like Ozempic and other weight-loss drugs that are actually diabetes drugs, provide me with retail insights,” said Pil, according to a takeaway featured in D CEO. “We can look through Chase’s anonymized data by individual—we bank more than 95 million individuals in this country—and I can identify people who are on Ozempic based on their spending patterns."
MORE►
A Special Thank you to our sponsors

A collaboration of the Dallas Regional Chamber and Dallas Next, Dallas Innovates is an online news platform covering what's new + next in Dallas - Fort Worth innovation.

© Copyright 2025 | All rights reserved.

Business

Creative

Education

Impact

Invention

Startup

Our Sponsors

Our Partners

Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.